0001882782-23-000001.txt : 20231215 0001882782-23-000001.hdr.sgml : 20231215 20231215161728 ACCESSION NUMBER: 0001882782-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231215 DATE AS OF CHANGE: 20231215 EFFECTIVENESS DATE: 20231215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Odyssey Therapeutics, Inc. CENTRAL INDEX KEY: 0001882782 IRS NUMBER: 863384382 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-499898 FILM NUMBER: 231490568 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (212) 841-1000 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001882782 Odyssey Therapeutics, Inc. 51 Sleeper Street Suite 800 Boston MA MASSACHUSETTS 02210 (212) 841-1000 DELAWARE None None Corporation true 2021 Gary D. Glick 51 Sleeper Street Suite 800 Boston MA MASSACHUSETTS 02210 Executive Officer Director Carl Gordon 51 Sleeper Street Suite 800 Boston MA MASSACHUSETTS 02210 Director Jill Carroll 51 Sleeper Street Suite 800 Boston MA MASSACHUSETTS 02210 Director Valerie Odegard 51 Sleeper Street Suite 800 Boston MA MASSACHUSETTS 02210 Director M. Charles Baum 51 Sleeper Street Suite 800 Boston MA MASSACHUSETTS 02210 Director Jeffrey Leiden 51 Sleeper Street Suite 800 Boston MA MASSACHUSETTS 02210 Director Lorence Kim 51 Sleeper Street Suite 800 Boston MA MASSACHUSETTS 02210 Director Biotechnology Decline to Disclose 06b false 2023-10-25 false true false 0 106000000 97130000 8870000 false 39 0 0 0 false Odyssey Therapeutics, Inc. /s/ Gary D. Glick Gary D. Glick President & CEO 2023-12-15